We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Charles River Laboratories (CRL) Common Stock USD0.01

Sell:$270.67 Buy:$270.95 Change: $1.81 (0.67%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$270.67
Buy:$270.95
Change: $1.81 (0.67%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$270.67
Buy:$270.95
Change: $1.81 (0.67%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Contact details

Address:
251 Ballardvale St
WILMINGTON
01887
United States
Telephone:
+1 (781) 2226000
Website:
https://www.criver.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CRL
ISIN:
US1598641074
Market cap:
$13.63 billion
Shares in issue:
51.35 million
Sector:
Life Sciences Tools & Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • James Foster
    Chairman of the Board, President, Chief Executive Officer
  • Flavia Pease
    Chief Financial Officer, Corporate Executive Vice President
  • Birgit Girshick
    Chief Operating Officer, Corporate Executive Vice President
  • Victoria Creamer
    Corporate Executive Vice President and Chief People Officer
  • William Barbo
    Executive Vice President, Strategic Advisor
  • Joseph LaPlume
    Corporate Executive Vice President - Corporate Development and Strategy
  • Shannon Parisotto
    Corporate Executive Vice President - Discovery and Safety Assessment Management
  • Kristen Eisenhauer
    Senior Vice President, Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.